<bill session="116" type="h" number="5480" updated="2022-10-28T01:46:15Z">
  <state datetime="2019-12-18">REFERRED</state>
  <status>
    <introduced datetime="2019-12-18"/>
  </status>
  <introduced datetime="2019-12-18"/>
  <titles>
    <title type="display">ALS Placebo No More Act</title>
    <title type="official" as="introduced">To ensure that ALS patients have access to treatment within clinical trials.</title>
    <title type="short" as="introduced">ALS Placebo No More Act</title>
  </titles>
  <sponsor bioguide_id="F000449"/>
  <cosponsors>
    <cosponsor bioguide_id="F000466" joined="2019-12-19"/>
    <cosponsor bioguide_id="G000579" joined="2019-12-19"/>
    <cosponsor bioguide_id="G000590" joined="2020-02-28"/>
  </cosponsors>
  <actions>
    <action datetime="2019-12-18">
      <text>Introduced in House</text>
    </action>
    <action datetime="2019-12-18" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2019-12-19">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Drug therapy"/>
    <term name="Medical research"/>
    <term name="Neurological disorders"/>
  </subjects>
  <amendments/>
  <summary date="2020-01-23T22:27:29Z" status="Introduced in House">ALS Placebo No More Act

This bill requires the Food and Drug Administration and the National Institutes of Health to collaborate to provide all patients with ALS (amyotrophic lateral sclerosis,&#160;also referred to as Lou Gehrig's disease) with access to medicines in clinical trials.</summary>
</bill>
